Attempts have been made to use the dexamethasone suppression test (DST) to distinguish patients who have a primary depressive disorder from those suffering a degenerative cerebral disorder. It has been suggested however, that organic brain damage reduces neuroendocrine sensitivity and can be associated with failure to suppress on the DST. This study investigates the DST in 21 patients, over 65 years, with dementia but no evidence of depression on a variety of clinical criteria. Seven patients had abnormal DSTs.
References
1.
ReiflerB. V.LarsonE.HanleyR. (1982) Coexistence of cognitive impairment and depression in geriatric outpatients. Am J Psychiatry, 139, 623–629.
2.
CarrollB. J.FeinbergM.GredenJ. F. (1981) A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry, 38, 15–22.
3.
McAllisterT. W.FerrellR. B.PriceT. R. P. (1982) The dexamethasone suppression test in two patients with severe depressive pseudodementia. Am J Psychiatry, 139, 479–481.
4.
RudorferM. V.ClaytonP. J. (1981) Depression, dementia and dexamethasone suppression (Letter)Am J Psychiatry, 138, 701.
5.
SparJ. E.GernerR. (1982) Does the dexamethasone suppression test distinguish dementia from depression?Am J Psychiatry. 139, 238–240.
6.
RaskindM.PeskindE.RivardM. F. (1982) et al. Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia. Am J Psychiatry, 139, 1468–1471.
7.
BrownW. A. (1982) The effect of age on DST results (Letter)Am J Psychiatry, 139, 1376–1377.
8.
Tourigny-RivardM. F.RaskindM.RivardD. (1981) The dexamethasone supression test in an elderly population. Biol Psychiatry. 16, 1177–1184.
